Biogen Inc (BIIB)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

133 BOSTON POST ROAD WESTON, MA 02493

Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The products of the Company include AVONEX, RITUXAN, TYSABRI and FUMADERM. The Company's products address diseases, such as multiple sclerosis (MS), non-Hodgkin's lymphoma (NHL), rheumatoid arthritis (RA), Crohn's disease (CD) and psoriasis. In addition to the marketed products, Biogen Idec has a number of product candidates in or near registrational stage development. It includes BG-12, Daclizumab, Fampridine, GA101, Humanized Anti-CD20 MAb (ocrelizumab), Lixiavaptan, Long-Acting rFactor IX and PEGylated interferon beta-1a. In December 2010, the Company and Neurimmune Holding AG announced that the Company had acquired a subsidiary of Neurimmune Holding AG.

Data based on most recent fiscal year report
Market Cap51.821 Billion Shares Outstanding180.44 Million Avg Volume2.483 Million
1-Yr BETA vs S&P TR0.669 Current Ratio2.32 Quick Ratio2.04
View SEC Filings from BIIB instead.

View recent insider trading info

Funds Holding BIIB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIIB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.1 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

1.9 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCANGOS GEORGE A

  • Director
1,086,626 2020-01-15 0

MACLEAN MICHAEL F CHIEF FINANCIAL OFFICER

  • Officer
48,000 2020-01-15 0

KOPPEL ADAM

  • Director
  • 10% Owner
5,558,425 2020-01-14 0

DENNER ALEXANDER J

  • Director
0 2020-01-06 3

KARABOUTIS ADRIANA

  • Director
5,431 2020-01-03 0

HASNAIN FAHEEM

3,000 2020-01-03 0

SCHENK LYNN

  • Director
0 2020-01-02 1

CAPELLO JEFFREY D EVP & CHIEF FINANCIAL OFFICER

  • Officer
1,813 2020-01-02 2

DUNN JOHN MICHAEL

  • Director
0 2020-01-02 0

DEKKERS MARIJN E

34,429 2020-01-02 0

HAWKINS WILLIAM A

  • Director
27,192 2020-01-02 2

CLANCY PAUL J

  • Director
2,457 2019-12-31 0

PAPADOPOULOS STELIOS

  • Director
0 2019-12-24 1

GAGNON ROBERT E. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-13 0

BEST LAWRENCE C

  • Director
60,790 2019-12-05 0

KRAMER ROBIN VP, CHIEF ACCOUNTING OFFICER

  • Officer
150 2019-12-03 2

POSNER BRIAN S

  • Director
6,995 2019-12-02 3

GUINDO CHIRFI EVP GLOB. PROD STRAT AND COMM

  • Officer
2,695 2019-12-01 2

YOUNG WILLIAM

  • Director
30,000 2019-11-22 0

SHARP PHILLIP A

  • Director
266,899 2019-11-18 0

WILLIAMS DOUGLAS E

  • Director
0 2019-11-13 0

GALDES ALPHONSE EVP PHARMACEUTICAL OPER & TECH

  • Officer
2,398 2019-09-19 1

WIGGINS MARK C

  • Director
0 2019-08-09 0

GREGORY GINGER EVP, HUMAN RESOURCES

  • Officer
2,215 2019-08-01 2

KARP DANIEL EVP, CORPORATE DEVELOPMENT

  • Officer
264 2019-07-02 2

HASLER HANS PETER

  • Director
10,000 2019-06-26 0

SHERWIN STEPHEN A

  • Director
0 2019-06-25 1

ROWINSKY ERIC K

  • Director
0 2019-06-21 1

LEAMING NANCY

  • Director
12,098 2019-06-19 1

PANGIA ROBERT W

  • Director
19,742 2019-06-19 2

DORSA CAROLINE

  • Director
20,207 2019-06-19 1

MULLIGAN RICHARD

  • Director
12,064 2019-06-19 1

MANTAS JESUS B

  • Director
1,155 2019-06-19 2

MULLEN JAMES C

  • Director
0 2019-06-12 0

EHLERS MICHAEL D EVP, RESEARCH AND DEVELOPMENT

  • Officer
8,025 2019-06-01 3

SANDROCK ALFRED

  • Director
0 2019-05-22 3

COX JOHN

  • Director
7,236 2019-05-15 0

VOUNATSOS MICHEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
21,829 2019-05-02 4

ALEXANDER SUSAN H

  • Director
36,198 2019-03-15 3

MCKENZIE PAUL EVP PHARMACEUTICAL OPER & TECH

  • Officer
7,235 2019-03-01 3

COVINO GREGORY F SVP, CAO, PAO

  • Officer
0 2019-01-22 0

KINGSLEY STUART A

  • Director
0 2018-06-08 0

DIPIETRO KENNETH

  • Director
0 2018-01-19 0

SCHNEIER CRAIG ERIC EVP AND CHIEF TALENT OFFICER

  • Officer
No longer subject to file 2017-08-29 0

KRESS JEAN-PAUL EVP PRES INT'L & GLOBAL HD GTO

  • Officer
0 2017-07-03 0

PICKETT CECIL B

  • Director
0 2017-05-12 0

LYTTON MICHAEL EVP, CORP DEVELOPMENT & STRTGY

  • Officer
386,292 2016-07-20 0

ARTAVANIS-TSAKONAS SPYRIDON EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
3,150 2016-04-02 0

HOLTZMAN STEVEN H EVP CORPORATE DEVELOPMENT

  • Officer
No longer subject to file 2016-02-23 0

PAWLICKI RAYMOND SVP, CHIEF INFORMATION OFFICER

  • Officer
8,710 2013-11-22 0

GRANATA FRANCESCO EVP GLOBAL COMMERCIAL OPERATIO

  • Officer
3,529 2012-02-01 0

ROSS BRUCE

  • Director
No longer subject to file 2010-06-08 0

HAMM ROBERT A CHIEF OPERATING OFFICER

  • Officer
27,212 2010-04-23 0

KELLER THOMAS F

  • Director
No longer subject to file 2008-09-29 0

GLASSBERG ALAN

  • Director
5,600 2008-06-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CAPELLO JEFFREY D - Officer EVP & CHIEF FINANCIAL OFFICER

2020-01-02 F 406 $294.20 d 1,813 1,813.00 direct

CAPELLO JEFFREY D - Officer EVP & CHIEF FINANCIAL OFFICER

2020-01-02 J 1,690 d 2,996 1,813.00 direct

CAPELLO JEFFREY D - Officer EVP & CHIEF FINANCIAL OFFICER

2020-01-02 M 1,302 a 2,219 1,813.00 direct

CAPELLO JEFFREY D - Officer EVP & CHIEF FINANCIAL OFFICER

2020-01-02 M 1,302 d 4,686 1,813.00 direct

KRAMER ROBIN - Officer VP, CHIEF ACCOUNTING OFFICER

2019-12-03 M 84 d 446 150.48 direct

KRAMER ROBIN - Officer VP, CHIEF ACCOUNTING OFFICER

2019-12-03 F 25 $290.70 d 150 150.48 direct

KRAMER ROBIN - Officer VP, CHIEF ACCOUNTING OFFICER

2019-12-03 J 92 d 354 150.48 direct

KRAMER ROBIN - Officer VP, CHIEF ACCOUNTING OFFICER

2019-12-03 M 84 a 175 150.48 direct

POSNER BRIAN S - Director

2019-12-02 S 1,055 $292.35 d 6,995 6,995.00 direct yes

GUINDO CHIRFI - Officer EVP GLOB. PROD STRAT AND COMM

2019-12-01 F 231 $299.81 d 2,312 2,695.00 direct

GUINDO CHIRFI - Officer EVP GLOB. PROD STRAT AND COMM

2019-12-01 F 160 $299.81 d 2,695 2,695.00 direct

GUINDO CHIRFI - Officer EVP GLOB. PROD STRAT AND COMM

2019-12-01 J 625 d 1,174 2,695.00 direct

GUINDO CHIRFI - Officer EVP GLOB. PROD STRAT AND COMM

2019-12-01 M 543 a 2,855 2,695.00 direct

GUINDO CHIRFI - Officer EVP GLOB. PROD STRAT AND COMM

2019-12-01 M 543 d 1,799 2,695.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments